Ocuphire Pharma Inc. (OCUP)
NASDAQ: OCUP
· Real-Time Price · USD
1.17
-0.16 (-12.03%)
At close: Oct 23, 2024, 10:00 PM
Ocuphire Pharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | -4.51M | 3.87M | 1.11M | 1.71M | 1.69M | 11.94M | 3.67M | 1.75M | 39.85M | n/a | n/a | n/a | -589K | 489K | 100K | n/a |
Cost of Revenue | n/a | n/a | 22.97M | 3K | 280K | 4.75M | 3K | 1K | 1K | 1K | 1K | 2.83M | 3.16M | 1K | 1K | 1K | 3.83M | 1K |
Gross Profit | n/a | n/a | -27.48M | 1.69M | 832K | -3.04M | 1.69M | 11.93M | 3.67M | 1.75M | 39.85M | -2.83M | -3.16M | -1K | -590K | 488K | -3.73M | -1K |
Operating Income | -8.91M | -9.93M | -38.03M | -8.01M | -8.33M | -7.71M | -5.43M | 6.39M | -5.39M | -6.13M | 34.21M | -4.54M | -4.94M | -6.51M | -6.15M | -4.23M | -7.14M | -5.19M |
Interest Income | n/a | n/a | -600K | 500K | n/a | 600K | n/a | n/a | 401K | 367K | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -7.42M | -8.19M | -35.13M | -7.53M | -7.76M | -7.11M | -4.8M | 5.58M | -4.96M | -5.79M | 34.26M | -4.53M | -4.93M | -6.59M | -6.31M | -4.23M | -7.14M | -39.01M |
Net Income | -7.42M | -8.19M | -35.13M | -7.53M | -7.76M | -7.11M | -4.79M | 5.56M | -4.96M | -5.45M | 33.94M | -4.53M | -4.93M | -6.68M | -6.31M | -4.23M | -7.14M | -39.01M |
Selling & General & Admin | 5.77M | 6.35M | 7.3M | 2.89M | 3.35M | 4.67M | 3.28M | 2.06M | 4.34M | 2.29M | 2.05M | 1.7M | 1.78M | 1.74M | 1.41M | 1.59M | 3.41M | 1.7M |
Research & Development | 6.02M | 7.95M | 7.03M | 8.98M | 6.09M | 4.75M | 3.84M | 3.49M | 4.72M | 5.59M | 3.59M | 2.83M | 3.16M | 4.77M | 4.74M | 3.13M | 3.83M | 3.48M |
Other Expenses | n/a | n/a | n/a | -4.76M | 563K | 2K | n/a | n/a | n/a | n/a | 46K | 7K | 15K | n/a | n/a | 2K | 1K | 1K |
Operating Expenses | 11.79M | 14.3M | 14.33M | 7.12M | 9.44M | 9.42M | 7.12M | 5.55M | 9.06M | 7.88M | 5.64M | 4.54M | 4.94M | 6.51M | 6.15M | 4.72M | 7.24M | 5.19M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9K | n/a | 4K | 5K | 2K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -6K | n/a | n/a | n/a | -3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | n/a | 42.33M | 11.88M | 9.44M | 9.42M | 7.12M | 5.55M | 9.06M | 7.88M | 5.64M | 4.54M | 4.94M | 6.51M | 6.15M | 4.72M | 7.24M | 5.19M |
Income Tax Expense | n/a | n/a | 5K | n/a | -1.5K | -1.5K | -2K | -14K | n/a | -340K | 315K | 7K | 19K | 87K | 2K | 1K | 1K | 1K |
Shares Outstanding (Basic) | 63.38M | 33.88M | 26.72M | 26.15M | 25.83M | 24.52M | 22.99M | 21.45M | 20.96M | 20.94M | 20.81M | 20.5M | 19.5M | 18.89M | 17.73M | 16.93M | 13.61M | 10.92M |
Shares Outstanding (Diluted) | 63.38M | 33.88M | 26.72M | 26.15M | 25.83M | 24.52M | 22.99M | 22.41M | 20.96M | 20.94M | 21.48M | 20.5M | 19.5M | 18.89M | 17.85M | 16.93M | 13.61M | 10.92M |
EPS (Basic) | -0.12 | -0.24 | -1.35 | -0.29 | -0.3 | -0.29 | -0.21 | 0.26 | -0.24 | -0.26 | 1.63 | -0.22 | -0.25 | -0.35 | -0.36 | -0.25 | -0.52 | -3.57 |
EPS (Diluted) | -0.12 | -0.24 | -1.35 | -0.29 | -0.3 | -0.29 | -0.21 | 0.25 | -0.24 | -0.26 | 1.58 | -0.22 | -0.25 | -0.35 | -0.35 | -0.25 | -0.52 | -3.57 |
EBITDA | -8.91M | -9.93M | -37.87M | -7.53M | -8.33M | -7.71M | -4.79M | 6.39M | -5.39M | -6.13M | 34.21M | -4.53M | -4.92M | -6.59M | -6.31M | -4.23M | -7.13M | -39.01M |
EBIT | n/a | n/a | 20.83M | -7.53M | -8.33M | -7.71M | -4.8M | 6.39M | -5.39M | -6.13M | 34.21M | -4.53M | -4.92M | -6.59M | -6.31M | -4.23M | -7.14M | -39.01M |
Depreciation & Amortization | n/a | n/a | -6K | n/a | 1.5K | 1.5K | 3K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K |